Delivery Order SPE2DB20D3101-SPE2DB23FRFZ9
Award Date 3/22/23
Potential Completion Date 3/23/23
Potential Value $4.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of NovologTM 100 unit/mL FlexPen 3mL to the Defense Logistics Agency (DLA). The $1,329.99 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 25, 2022, with a completion date of March 28, 2022. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,225.44 Firm Fixed Price delivery order contract is for the supply of NovologTM 100 unit/mL FlexPenTM 3mL, a medication used for diabetes management. The contract has an ultimate completion date of February 13, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of NovoLog 100 unit/mL FlexPen 3mL, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,275.80, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on March 15, 2024. This is a delivery order contract with a firm fixed price, and the ultimate completion date is March 18, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of NovologTM 100 Unit/mL FlexPen 3mL, a prescription medication, to the Defense Logistics Agency (DLA). The $4,035.14 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 1, 2024 and is not designated as a set-aside requirement. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds significant...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,225.44 firm fixed price delivery order to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Novolog 100 Unit/mL Flexpen 3mL insulin pens. The contract has a ceiling value of $3,111.20 and a period of performance through May 31, 2024. It is a firm fixed price delivery order contract, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Novolog 100 Unit/mL FlexPen 3mL insulin products. The $1,810.80 fixed-price delivery order has a completion date of September 27, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as the primary vehicle for providing...
- This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, and has a ceiling value of $1,318.08. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC is valued at up to $999,999,999.00 and runs...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NovologTM 100 unit/mL Flexpen 3 mL. The contract has a ceiling value of $1,433.68 and a completion date of July 18, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of NovologÒ 100 Unit/mL FlexPenÒ 3mL medical supplies. The $1,274.60 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of October 6, 2023. The contract is not designated with any set-aside requirements. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...